Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Eton Pharmaceuticals Inc

ETON
Current price
14.79 USD +0.38 USD (+2.64%)
Last closed 14.22 USD
ISIN US29772L1089
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 236 917 952 USD
Yield for 12 month +281.19 %
1Y
3Y
5Y
10Y
15Y
ETON
21.11.2021 - 28.11.2021

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. Address: 21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.00 USD

P/E ratio

Dividend Yield

Current Year

+31 642 000 USD

Last Year

+21 251 000 USD

Current Quarter

+10 324 000 USD

Last Quarter

+9 074 000 USD

Current Year

+21 061 000 USD

Last Year

+14 318 000 USD

Current Quarter

+6 302 000 USD

Last Quarter

+5 626 000 USD

Key Figures ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 314 000 USD
Operating Margin TTM -32.35 %
Price to Earnings
Return On Assets TTM -12.50 %
PEG Ratio
Return On Equity TTM -44.30 %
Wall Street Target Price 13.00 USD
Revenue TTM 31 381 000 USD
Book Value 0.52 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -24.40 %
Dividend Yield
Gross Profit TTM 14 318 000 USD
Earnings per share -0.26 USD
Diluted Eps TTM -0.26 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -12.60 %
Profit Margin -21.31 %

Dividend Analytics ETON

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 33.33
Enterprise Value Revenue 8.74
Price Sales TTM 10.49
Enterprise Value EBITDA 51.26
Price Book MRQ 19.97

Financials ETON

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ETON

For 52 weeks

3.03 USD 13.98 USD
50 Day MA 6.96 USD
Shares Short Prior Month 206 511
200 Day MA 4.59 USD
Short Ratio 0.95
Shares Short 273 898
Short Percent 0.83 %
Dividend information is being updated